André, Fabrice

Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy

Di Meglio, A., Havas, J., Gbenou, A. S., Martin, E., El-Mouhebb, M., Pistilli, B., Menvielle, G., Dumas, A., Everhard, S., Martin, A.-L., et al. (2022) · Journal of Clinical Oncology

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 76

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

Hurvitz, S. A., Dalenc, F., Campone, M., O’Regan, R. M., Tjan-Heijnen, V. C., Gligorov, J., Llombart, A., Jhangiani, H., Mirshahidi, H. R., Tan-Chiu, E., et al. (2013) · Breast Cancer Research and Treatment

HER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer

Cited by 76

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

Vaz-Luis, I., Di Meglio, A., Havas, J., El-Mouhebb, M., Lapidari, P., Presti, D., Soldato, D., Pistilli, B., Dumas, A., Menvielle, G., et al. (2022) · Journal of Clinical Oncology

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 65

Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

Goubet, A.-G., Wheeler, R., Fluckiger, A., Qu, B., Lemaître, F., Iribarren, K., Mondragón, L., Tidjani Alou, M., Pizzato, E., Durand, S., et al. (2021) · Cell Death & Differentiation

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 54

Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France

Charles, C., Bardet, A., Larive, A., Gorwood, P., Ramoz, N., Thomas, E., Viari, A., Rousseau-Tsangaris, M., Dumas, A., Menvielle, G., et al. (2022) · JAMA Network Open

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 50

Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium

Franzoi, M. A., Ferreira, A. R., Lemaire, A., Rodriguez, J., Grosjean, J., Ribeiro, J. M., Polastro, L., Grellety, T., Artignan, X., Le Du, K., et al. (2024) · The Lancet Regional Health - Europe

Telemedicine and Telehealth ImplementationCancer survivorship and care

Cited by 50

Efficacy and safety of immune checkpoint blockade in patients with Li-Fraumeni syndrome

Bottosso, M., Verret, B., Caron, O., Hamzaoui, N., Pasmant, E., Danlos, F.-X., Boudou-Rouquette, P., Srikaran, A., Blons, H., Guarneri, V., et al. (2024) · JCO Precision Oncology

Cancer Immunotherapy and BiomarkersImmunodeficiency and Autoimmune Disorders

Cited by 6